CNTX - CIK 0001842952
The table below shows Context Therapeutics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $2.33M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.89M |
| $1.93M |
| $2.07M |
| $1.88M |
| $1.70M |
| Operating income | -$9.34M | -$10.61M | -$9.76M | -$5.53M | -$18.70M | -$3.09M |
| Income tax | - | - | - | - | - | - |
| Net income | -$8.68M | -$9.69M | -$8.83M | -$4.58M | -$17.46M | -$2.25M |
| EPS (diluted) | -$0.09 | -$0.10 | -$0.09 | -$0.05 | -$0.22 | -$0.04 |